Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$892M |
| 2 |
Merck
MRK
|
+$858M |
| 3 |
Amgen
AMGN
|
+$857M |
| 4 |
Home Depot
HD
|
+$837M |
| 5 |
Cisco
CSCO
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$776M |
| 2 |
United Parcel Service
UPS
|
+$615M |
| 3 |
Qualcomm
QCOM
|
+$587M |
| 4 |
Alibaba
BABA
|
+$555M |
| 5 |
Eaton
ETN
|
+$508M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 11.88% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Karyopharm Therapeutics
KPTI
$44.6M
| $4.76M | ﹤0.01% |
30,150
-988
| -3% | -$208K |
|
|
JAMF
2327
DELISTED
Jamf
JAMF
| $4.75M | ﹤0.01% |
134,616
+5,458
| +4% | +$199K |
|
2328
Stoke Therapeutics
STOK
$1.84B
| $4.75M | ﹤0.01% |
122,360
+6,363
| +5% | +$362K |
|
|
SGFY
2329
DELISTED
Signify Health, Inc.
SGFY
| $4.75M | ﹤0.01% |
+162,139
| New | +$5.02M |
|
|
WSR
2330
DELISTED
Whitestone REIT
WSR
| $4.74M | ﹤0.01% |
488,124
+78,102
| +19% | +$699K |
|
|
GOOD
2331
Gladstone Commercial Corp
GOOD
$604M
| $4.71M | ﹤0.01% |
240,963
+13,872
| +6% | +$262K |
|
|
CIVI
2332
DELISTED
Civitas Resources
CIVI
| $4.71M | ﹤0.01% |
131,895
+10,465
| +9% | +$295K |
|
2333
MiMedx Group
MDXG
$622M
| $4.7M | ﹤0.01% |
455,938
+13,994
| +3% | +$135K |
|
|
EFC
2334
Ellington Financial
EFC
$1.67B
| $4.7M | ﹤0.01% |
293,253
+9,280
| +3% | +$146K |
|
2335
Prothena Corp
PRTA
$436M
| $4.68M | ﹤0.01% |
186,391
+3,852
| +2% | +$72.5K |
|
|
CLVS
2336
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.66M | ﹤0.01% |
664,334
+90,535
| +16% | +$607K |
|
|
VBIV
2337
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $4.63M | ﹤0.01% |
49,658
+2,912
| +6% | +$295K |
|
|
NKLA
2338
DELISTED
Nikola Corporation Common Stock
NKLA
| $4.62M | ﹤0.01% |
11,090
+1,893
| +21% | +$1.08M |
|
2339
Republic Bancorp
RBCAA
$1.95B
| $4.61M | ﹤0.01% |
104,101
+1,938
| +2% | +$80.2K |
|
2340
Outset Medical
OM
$92.5M
| $4.61M | ﹤0.01% |
5,647
+137
| +2% | +$106K |
|
2341
Ranpak Holdings
PACK
$465M
| $4.6M | ﹤0.01% |
229,378
+6,836
| +3% | +$127K |
|
|
XENT
2342
DELISTED
Intersect ENT, Inc
XENT
| $4.6M | ﹤0.01% |
220,185
+4,778
| +2% | +$110K |
|
2343
BrightView Holdings
BV
$1.26B
| $4.58M | ﹤0.01% |
271,287
+49,344
| +22% | +$790K |
|
2344
Seer Inc
SEER
$123M
| $4.56M | ﹤0.01% |
+91,135
| New | +$5.33M |
|
2345
Mitek Systems
MITK
$767M
| $4.56M | ﹤0.01% |
312,419
-132,269
| -30% | -$2.12M |
|
2346
Personalis
PSNL
$1.41B
| $4.55M | ﹤0.01% |
184,749
+30,315
| +20% | +$1.04M |
|
2347
Amphastar Pharmaceuticals
AMPH
$892M
| $4.54M | ﹤0.01% |
247,899
+5,751
| +2% | +$107K |
|
2348
First Mid Bancshares
FMBH
$1.4B
| $4.54M | ﹤0.01% |
103,345
+6,275
| +6% | +$237K |
|
2349
Inseego
INSG
$120M
| $4.54M | ﹤0.01% |
45,398
+1,787
| +4% | +$260K |
|
2350
Grupo Cibest SA
CIB
$21.6B
| $4.53M | ﹤0.01% |
141,672
+4,907
| +4% | +$174K |
|
Similar funds
Charles Schwab's Q1 2021 Portfolio in Review
As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
- Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
- Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
- Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
- Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
- Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.